DUGGAN ROBERT W 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-13 5:54 pm Purchase | 2024-09-11 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 555,736,060 75.200% | 379,871,779 (+216.00%) | Filing |
| 2023-02-16 4:01 pm Unchanged | 2023-02-07 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 78.100% | 0 (Unchanged) | Filing |
| 2022-12-09 5:24 pm Purchase | 2022-12-06 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 81.800% | 9,346,434 (+5.61%) | Filing |
| 2022-08-18 4:43 pm Purchase | 2022-08-16 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 166,517,847 81.150% | 94,870,338 (+132.41%) | Filing |
| 2021-05-14 4:27 pm Purchase | 2021-05-12 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 71,647,509 70.780% | 11,365,921 (+18.85%) | Filing |
| 2021-04-22 5:11 pm Unchanged | 2021-04-20 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing |
| 2021-03-26 5:07 pm Unchanged | 2021-03-24 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing |
| 2020-11-10 4:11 pm Purchase | 2020-11-06 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.940% | 4,341,317 (+7.76%) | Filing |
| 2020-10-06 7:28 pm Purchase | 2020-10-02 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 55,940,271 69.110% | 9,730,539 (+21.06%) | Filing |
| 2020-09-28 4:37 pm Purchase | 2020-09-18 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 46,209,732 64.890% | 46,209,732 (New Position) | Filing |